INO (STOCKS)
Inovio Pharmaceuticals, Inc.
$0.920600
+0.150600 (+19.56%)
Prev close: $0.770000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jacqueline E. Shea
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $105.88M
- Employees
- 134
- P/E (TTM)
- -0.45
- P/B (TTM)
- 8.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.28 | $-0.35 | +0.0735 | +20.79% |
|
Dec 2025 (Q4)
|
$0.06 | $-0.36 | +0.4214 | +116.60% |
|
Sep 2025 (Q3)
|
$-0.87 | $-0.43 | -0.4426 | -103.56% |
|
Jun 2025 (Q2)
|
$-0.61 | $-0.62 | +0.0053 | +0.86% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $83.72M |
| Research and Development | $52.19M |
| Other Operating Expenses | $31.54M |
| Operating Income/Loss | -$83.72M |
| Income/Loss From Continuing Operations After Tax | -$84.93M |
| Income/Loss From Continuing Operations Before Tax | -$173.71M |
| Net Income/Loss | -$84.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$84.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$84.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.45 |
| Diluted Earnings Per Share | -$1.45 |
| Basic Average Shares | 165,149,114 |
| Diluted Average Shares | 165,149,114 |
| Assets | $49.78M |
| Current Assets | $39.44M |
| Cash | $37.70M |
| Other Current Assets | $1.74M |
| Noncurrent Assets | $10.34M |
| Fixed Assets | $2.21M |
| Other Non-current Assets | $8.13M |
| Liabilities | $43.71M |
| Current Liabilities | $37.92M |
| Noncurrent Liabilities | $5.79M |
| Equity | $6.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.07M |
| Liabilities And Equity | $49.78M |
| Net Cash Flow From Operating Activities | -$83.35M |
| Net Cash Flow From Operating Activities, Continuing | -$83.35M |
| Net Cash Flow From Investing Activities | $16.73M |
| Net Cash Flow From Investing Activities, Continuing | $16.73M |
| Net Cash Flow From Financing Activities | $52.98M |
| Net Cash Flow From Financing Activities, Continuing | $52.98M |
| Net Cash Flow | -$13.64M |
| Net Cash Flow, Continuing | -$13.64M |
| Comprehensive Income/Loss | -$84.91M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$84.91M |
| Other Comprehensive Income/Loss | -$61.39M |